CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 54 enrolled
Drug / intervention
Citalopram +1 moredrug
Likely dose
Citalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02080832
NCT02080832Phase 2Completed
CompareCT.gov

Brain Function and Structure in Cocaine Dependence

Virginia Commonwealth University·interventional·Posted Mar 6, 2014·Updated Dec 26, 2017

In Brief

A Phase 2 clinical trial evaluating Citalopram and Placebo for Cocaine Dependence. Completed, enrolled 54 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the role of brain MRI findings in predicting treatment outcomes among individuals with cocaine dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
CollaboratorsThe University of Texas Health Science Center, Houston, National Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 6, 2014
Enrollment StartFeb 1, 2010
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 12.3 years ago

Interventions

Citalopramdrug

20 mg or 40 mg daily for 8 weeks

Placebodrug

Placebo daily for 8 weeks